Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Santica Research Labs is a biotechnology company focused on the discovery and development of novel therapeutics designed to extend human healthspan and address age-related diseases. The company's primary focus is on the activation of Sirtuin 6 (SIRT6), a key protein known as the longevity protein due to its essential roles in DNA repair, telomere maintenance, and metabolic homeostasis. Santica Research Labs utilizes a proprietary platform to identify and optimize small molecule SIRT6 activators, with the goal of developing treatments for conditions such as metabolic syndrome, frailty, and other aging-associated pathologies. The company is currently in the pre-clinical stage of development for its lead SIRT6 activation programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Santica Research Labs.